RhumbLine Advisers’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.61M Buy
184,724
+9,292
+5% +$484K 0.01% 1068
2025
Q1
$7.47M Buy
175,432
+8,202
+5% +$349K 0.01% 1155
2024
Q4
$5.11M Buy
167,230
+3,529
+2% +$108K ﹤0.01% 1409
2024
Q3
$3.76M Sell
163,701
-9,597
-6% -$220K ﹤0.01% 1574
2024
Q2
$5M Buy
173,298
+10,162
+6% +$293K ﹤0.01% 1400
2024
Q1
$3.37M Buy
163,136
+3,890
+2% +$80.3K ﹤0.01% 1626
2023
Q4
$4.31M Sell
159,246
-414
-0.3% -$11.2K ﹤0.01% 1509
2023
Q3
$4.73M Buy
159,660
+8,688
+6% +$258K 0.01% 1384
2023
Q2
$5.4M Buy
150,972
+29,315
+24% +$1.05M 0.01% 1329
2023
Q1
$2.85M Buy
121,657
+11,406
+10% +$267K ﹤0.01% 1627
2022
Q4
$3M Buy
110,251
+4,099
+4% +$111K ﹤0.01% 1573
2022
Q3
$5.71M Buy
106,152
+8,536
+9% +$459K 0.01% 1152
2022
Q2
$3.94M Buy
97,616
+15,962
+20% +$644K 0.01% 1379
2022
Q1
$5.41M Sell
81,654
-4,578
-5% -$303K 0.01% 1258
2021
Q4
$8.63M Buy
86,232
+2,708
+3% +$271K 0.01% 1063
2021
Q3
$10.4M Sell
83,524
-708
-0.8% -$88.5K 0.01% 929
2021
Q2
$10.5M Sell
84,232
-268
-0.3% -$33.3K 0.01% 972
2021
Q1
$12.9M Sell
84,500
-2,552
-3% -$390K 0.02% 838
2020
Q4
$11.2M Buy
87,052
+5,358
+7% +$691K 0.02% 846
2020
Q3
$9.13M Sell
81,694
-4,645
-5% -$519K 0.01% 824
2020
Q2
$7.01M Buy
86,339
+48,550
+128% +$3.94M 0.01% 984
2020
Q1
$2.63M Buy
37,789
+965
+3% +$67.2K 0.01% 1395
2019
Q4
$2.88M Buy
36,824
+983
+3% +$76.8K ﹤0.01% 1587
2019
Q3
$2.29M Buy
35,841
+1,538
+4% +$98.2K ﹤0.01% 1669
2019
Q2
$2.96M Buy
34,303
+14,056
+69% +$1.21M 0.01% 1489
2019
Q1
$1.55M Buy
20,247
+367
+2% +$28.2K ﹤0.01% 1842
2018
Q4
$747K Buy
+19,880
New +$747K ﹤0.01% 2131